Rathbones Group’s Clover Health Investments CLOV Stock Holding History

Rathbones Group’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$115K	Sell	22,000 -1,000	-4%	-$3.4K	﹤0.01%	632
2026 Q1	$40.5K	Hold	23,000	–	–	﹤0.01%	637
2025 Q4	$54K	Hold	23,000	–	–	﹤0.01%	620
2025 Q3	$70.4K	Hold	23,000	–	–	﹤0.01%	618
2025 Q2	$64.2K	Hold	23,000	–	–	﹤0.01%	599
2025 Q1	$82.6K	Hold	23,000	–	–	﹤0.01%	566
2024 Q4	$72.5K	Hold	23,000	–	–	﹤0.01%	578
2024 Q3	$64.9K	Sell	23,000 -2,000	-8%	-$4.58K	﹤0.01%	576
2024 Q2	$30.8K	Hold	25,000	–	–	﹤0.01%	603
2024 Q1	$19.9K	Hold	25,000	–	–	﹤0.01%	606
2023 Q4	$23.8K	Sell	25,000 -63	-0.3%	-$62	﹤0.01%	603
2023 Q3	$27.1K	Buy	+25,063	New	+$29.8K	﹤0.01%	613

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Rathbones Group's CLOV Position: Q2 2026 in Review

Rathbones Group reduced its Clover Health Investments (CLOV) stake by 4.3% in Q2 2026, selling an estimated $3.4K and leaving 22,000 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Rathbones Group first reported a position in CLOV in Q3 2023 and has held it in 12 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Rathbones Group held 22,000 shares of Clover Health Investments worth $115K as of Q2 2026.
Rathbones Group sold 1,000 Clover Health Investments shares in Q2 2026, an estimated $3.4K.
Clover Health Investments made up ﹤0.01% of Rathbones Group's portfolio in Q2 2026, its #632 holding.
Rathbones Group first reported a position in Clover Health Investments in Q3 2023 and has held it in 12 quarters since.
226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.